{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T10:37:26Z","timestamp":1717151846720},"reference-count":20,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1614,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1111\/j.1600-0609.2011.01604.x","type":"journal-article","created":{"date-parts":[[2011,3,9]],"date-time":"2011-03-09T15:29:09Z","timestamp":1299684549000},"page":"512-516","source":"Crossref","is-referenced-by-count":3,"title":["Lack of efficacy of pyridoxine (vitamin B6) treatment in acquired idiopathic sideroblastic anaemia, including refractory anaemia with ring sideroblasts"],"prefix":"10.1111","volume":"86","author":[{"given":"Lisa M.","family":"Baumann Kreuziger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra P.","family":"Wolanskyj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curtis A.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"Steensma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,4,1]]},"reference":[{"key":"10.1111\/j.1600-0609.2011.01604.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1046\/j.0007-1048.2002.03378.x","article-title":"Sideroblastic anaemias","volume":"116","author":"Alcindor","year":"2002","journal-title":"British Journal of Haematology"},{"key":"10.1111\/j.1600-0609.2011.01604.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1053\/j.seminhematol.2009.07.001","article-title":"Hereditary sideroblastic anemias: pathophysiology, diagnosis, and treatment","volume":"46","author":"Camaschella","year":"2009","journal-title":"Semin Hematol"},{"key":"10.1111\/j.1600-0609.2011.01604.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","article-title":"Proposals for the classification of the myelodysplastic syndromes","volume":"51","author":"Bennett","year":"1982","journal-title":"British Journal of Haematology"},{"key":"10.1111\/j.1600-0609.2011.01604.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2011.01604.x-BIB5|cit5","volume-title":"Indepedent Validation of the 2008 World Health Organization (WHO) Reclassification of Myelodysplastic Syndromes (MDS) Associated with Ring Sideroblasts","author":"Steensma","year":"2008"},{"key":"10.1111\/j.1600-0609.2011.01604.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.leukres.2006.06.005","article-title":"Candidate gene mutation analysis in idiopathic acquired sideroblastic anemia (refractory anemia with ringed sideroblasts)","volume":"31","author":"Steensma","year":"2007","journal-title":"Leuk Res"},{"key":"10.1111\/j.1600-0609.2011.01604.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1182\/blood.V84.11.3915.bloodjournal84113915","article-title":"X-linked sideroblastic anemia: identification of the mutation in the erythroid-specific delta-aminolevulinate synthase gene (ALAS2) in the original family described by Cooley","volume":"84","author":"Cotter","year":"1994","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2011.01604.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/ajcn\/43.3.374","article-title":"Intestinal hydrolysis of pyridoxal 5\u2032-phosphate in vitro and in vivo in the rat: effect of ethanol","volume":"43","author":"Middleton","year":"1986","journal-title":"Am J Clin Nutr"},{"key":"10.1111\/j.1600-0609.2011.01604.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-2141.1965.tb00088.x","article-title":"Antituberculous drugs and sideroblastic anaemia","volume":"11","author":"Verwilghen","year":"1965","journal-title":"British Journal of Haematology"},{"key":"10.1111\/j.1600-0609.2011.01604.x-BIB10|cit10","first-page":"1533","article-title":"[Acquired, vitamin B6-responsive, primary sideroblastic anemia, an enzyme deficiency in heme synthesis]","volume":"111","author":"Meier","year":"1981","journal-title":"Schweiz Med Wochenschr"},{"key":"10.1111\/j.1600-0609.2011.01604.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.0954-6820.1961.tb17100.x","article-title":"Favourable effect of pyridoxine and ascorbic acid in a patient with refractory sideroblastic anaemia and haemochromatosis","volume":"169","author":"Vuylsteke","year":"1961","journal-title":"Acta Medica Scandinavica"},{"key":"10.1111\/j.1600-0609.2011.01604.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2141.1965.tb00085.x","article-title":"Sideroblastic anaemia in man: observations on seventy cases","volume":"11","author":"Macgibbon","year":"1965","journal-title":"British Journal of Haematology"},{"key":"10.1111\/j.1600-0609.2011.01604.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2141.1984.tb01281.x","article-title":"Late onset pyridoxine-responsive sideroblastic anaemia after allogeneic bone marrow transplantation","volume":"56","author":"Nicholls","year":"1984","journal-title":"British Journal of Haematology"},{"key":"10.1111\/j.1600-0609.2011.01604.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1212\/WNL.35.10.1466","article-title":"Sensory neuropathy with low-dose pyridoxine","volume":"35","author":"Parry","year":"1985","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0609.2011.01604.x-BIB15|cit15","first-page":"131","article-title":"World Health Organization classification of the acute leukemias and myelodysplastic syndrome","volume":"72","author":"Bennett","year":"2000","journal-title":"Int J Hematol"},{"key":"10.1111\/j.1600-0609.2011.01604.x-BIB16|cit16","volume-title":"World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"Jaffe","year":"2001"},{"key":"10.1111\/j.1600-0609.2011.01604.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood-2005-10-4149","article-title":"Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia","volume":"108","author":"Cheson","year":"2006","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2011.01604.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1172\/JCI118258","article-title":"Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts","volume":"96","author":"Cotter","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1600-0609.2011.01604.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1182\/blood.V78.7.1658.1658","article-title":"Pharmacologic doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromes","volume":"78","author":"Stein","year":"1991","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2011.01604.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2141.1990.tb02536.x","article-title":"Two types of acquired idiopathic sideroblastic anaemia (AISA)","volume":"74","author":"Gattermann","year":"1990","journal-title":"British Journal of Haematology"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.2011.01604.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0609.2011.01604.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T05:27:47Z","timestamp":1625635667000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.2011.01604.x"}},"subtitle":["Lack of efficacy of pyridoxine (vitamin B6) treatment"],"short-title":[],"issued":{"date-parts":[[2011,4,1]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.2011.01604.x","relation":{},"ISSN":["0902-4441"],"issn-type":[{"value":"0902-4441","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4,1]]}}}